UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): September 2, 2011
Apricus Biosciences, Inc.
(Exact name of registrant as specified in its charter)
Nevada | 0-22245 | 87-0449967 | ||
(State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
6330 Nancy Ridge Drive, Suite 103, San Diego, California | 92121 | |
(Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: (858) 222-8041
Not Applicable
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
On September 2, 2011, Apricus Biosciences, Inc. issued a press release correcting the terminology relating to its over-the-counter products. A copy of the release is attached hereto as Exhibit 99.1.
(d) Exhibits. The following exhibit is filed with this report on Form 8-K:
Exhibit Number | Description of Exhibit | |
99.1 | Press Release, dated September 2, 2011. | |
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
September 2, 2011 | Apricus Biosciences, Inc. | |||
By: | /s/ Randy Berholtz | |||
Randy Berholtz | ||||
Executive Vice President, General Counsel and Secretary |
Exhibit Number | Description of Exhibit | |
99.1 | Press Release, dated September 2, 2011. |